home / stock / agrx / agrx news


AGRX News and Press, Agile Therapeutics Inc. From 10/12/21

Stock Information

Company Name: Agile Therapeutics Inc.
Stock Symbol: AGRX
Market: OTC
Website: agiletherapeutics.com

Menu

AGRX AGRX Quote AGRX Short AGRX News AGRX Articles AGRX Message Board
Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

AGRX - Agile Therapeutics Applauds Congressional Chairs' Letter to Biden Administration Requesting Enforcement of Contraceptive Access Under Affordable Care Act

PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the Secretaries of U.S. Departments of Health and Human Services (HHS), Treasury, and La...

AGRX - Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants

PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 26,666,648 shares of its common stock and warrants to purchase 13,333,324 shares of its common ...

AGRX - Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants

PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offerin...

AGRX - Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary

PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX ), a women's healthcare company, announced today that the California Medicaid Program, Medi-Cal, has placed Twirla on the preferred drug formulary list as of October 1, 2021. This development s...

AGRX - Agile Therapeutics Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics

PRINCETON, N.J., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX ), a women's healthcare company, announced today a partnership with U.S. Women’s Soccer legend, Carli Lloyd . The partnership with Agile will focus on bringing awareness to women&#x...

AGRX - Agile Therapeutics to Participate in Upcoming Investor Conferences

PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the following virtual investor conferences during the month of September 2021. H.C. Wainwri...

AGRX - Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women's Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system

Pandia Health is a doctor founded and led telehealth company, offering online prescriptions and free delivery designed to make it easier for women to access birth control options that meet their needs Partnership represents first telehealth alliance for Agile’s Twir...

AGRX - Agile Therapeutics: Another Quarter Of Progress And Another Opportunity To Buy

Agile Therapeutics recently reported their Q2 earnings with a beat on EPS and a miss on revenue. The company’s flagship product, Twirla, is already starting to display impressive growth trends. The market had a difficult time determining which direction it wants to take the sha...

AGRX - Agile Therapeutics (AGRX) Q2 2021 Earnings Call Transcript

Image source: The Motley Fool. Agile Therapeutics (NASDAQ: AGRX) Q2 2021 Earnings Call Jul 26, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Agile Therapeutics (AGRX) Q2 2021 Earnings Call Transcript

AGRX - Agile Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Agile Therapeutics, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Agile Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation

Previous 10 Next 10